Investor profile
GHO Capital
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
GHO Capital is Europe's leading specialist healthcare private equity investor, applying global capabilities and perspectives to unlock high-growth healthcare opportunities. The firm targets Pan-European and transatlantic internationalisation to build market-leading businesses of strategic global value, partnering with strong management teams to generate long-term sustainable value and improve the efficiency of healthcare delivery. GHO's four investment themes are: Optimising Product Development and Manufacture; Advancing Innovative and Targeted Therapeutics; Accelerating Strategic Decision Making and Market Access; and Improving Healthcare Efficiencies Through Innovative Business Models, Systems and Tools — all in service of its mission to deliver 'Better, Faster and More Accessible Healthcare.'
Notable quotes
“We are witnessing a golden era of healthcare innovation, driven by the convergence of advanced science, digital technologies, and data. GHO Capital is at the forefront.”
“Our mission at GHO is to make healthcare better, faster and more accessible, and at the heart of this is enabling efficient, high-quality manufacturing of innovative treatments. Avid exemplifies this perfectly – the company operates in high-growth markets, producing complex biologics for leading pharmaceutical and biotech innovators at both the clinical and commercial stages.”
“This transaction represents a pivotal moment in the evolution of both firms. Our vision has always been to back high-growth, innovation-led healthcare opportunities to deliver better, faster and more accessible healthcare.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Avid Bioservices | Buyout | $1.1b | 2025-02-05 |
| Scientist.com | Buyout | — | 2025 |
| FotoFinder Systems | Buyout | — | 2025 |
| Alcami Corporation | Buyout | — | 2022 |
| Velocity Clinical Research | Buyout | — | 2021 |
| RoslinCT | Buyout | — | 2021 |
| Biocare Medical | Buyout | — | 2020 |
| Genesis Research | Buyout | — | 2020 |
| Sanner | Buyout | — | 2019 |
| ELIQUENT Life Sciences | Buyout | — | 2022 |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Ampersand Capital Partners | 1 |
| Excellere Partners | 1 |
Fit check
Is GHO Capital a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit